Eli Lilly and Co
Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility
Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend ...
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
Digital health companies are launching programs around GLP-1s
Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and ...
Eli Lilly invests to increase Mounjaro, Zepbound supply
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. ...
AstraZeneca to boost revenue, release new medicines by 2030
The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | ...
Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide
Amgen‘s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss ...
Weight loss drug patients spend less on restaurants, takeout: survey
A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023. Jeenah Moon | ...
